1-5 of 5
Matthew Matasar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CHRONOS-4: phase 3 study of copanlisib plus rituximab-based immunochemotherapy in relapsed indolent B-cell lymphoma

Clinical Trials & Observations
Pier Luigi Zinzani, Huaqing Wang, Jifeng Feng, Tae Min Kim, Rong Tao, Huilai Zhang, Laura Fogliatto, Clara Maluquer Artigal, Muhit Özcan, Eduardo Yanez, Won Seog Kim, Dmitry Kirtbaya, Iryna Kriachok, Felipe Maciel, Hongwei Xue, Krimo Bouabdallah, Charles Phelps, Shalini Chaturvedi, Anke Weispfenning, Peter N. Morcos, Fatuma Odongo, Viktoriya Buvaylo, Barrett H. Childs, Martin Dreyling, Matthew Matasar, Paola Ghione
Journal: Blood Advances
Blood Adv (2024) 8 (18): 4866–4876.
https://doi.org/10.1182/bloodadvances.2024013236
Published: 2024
Includes: Supplemental data
Journal Articles

Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma

Clinical Trials & Observations
Nancy L. Bartlett, Sarit Assouline, Pratyush Giri, Stephen J. Schuster, Chan Y. Cheah, Matthew Matasar, Gareth P. Gregory, Dok Hyun Yoon, Mazyar Shadman, Keith Fay, Sung-Soo Yoon, Carlos Panizo, Ian Flinn, Anna Johnston, Francesc Bosch, Laurie H. Sehn, Michael C. Wei, Shen Yin, Iris To, Chi-Chung Li, Huang Huang, Antonia Kwan, Elicia Penuel, Lihua E. Budde
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4926–4935.
https://doi.org/10.1182/bloodadvances.2022009260
Published: 2023
Includes: Supplemental data
Journal Articles

A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma

Clinical Trials & Observations
David Qualls, Hiu Ying Lam, Karissa Whiting, Anita Kumar, Matthew Matasar, Colette Owens, Chelsea Nichols, James A Espeleta, Annie Qiu, Sarima Subzwari, Erin Biggar, Venkatraman Seshan, Gilles Salles, Anas Younes, Connie Batlevi
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5262–5266.
https://doi.org/10.1182/bloodadvances.2021006555
Published: 2022
Includes: Supplemental data
Journal Articles

Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies

Clinical Trials & Observations
David Sermer, Connie Batlevi, M. Lia Palomba, Gunjan Shah, Richard J. Lin, Miguel-Angel Perales, Michael Scordo, Parastoo Dahi, Martina Pennisi, Aishat Afuye, Mari Lynne Silverberg, Caleb Ho, Jessica Flynn, Sean Devlin, Philip Caron, Audrey Hamilton, Paul Hamlin, Steven Horwitz, Erel Joffe, Anita Kumar, Matthew Matasar, Ariela Noy, Colette Owens, Alison Moskowitz, David Straus, Gottfried von Keudell, Ildefonso Rodriguez-Rivera, Lorenzo Falchi, Andrew Zelenetz, Joachim Yahalom, Anas Younes, Craig Sauter
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4669–4678.
https://doi.org/10.1182/bloodadvances.2020002118
Published: 2020
Includes: Supplemental data
Journal Articles

Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma

Clinical Trials & Observations
David Sermer, Sabela Bobillo, Ahmet Dogan, Yanming Zhang, Venkatraman Seshan, Jessica A. Lavery, Connie Batlevi, Philip Caron, Audrey Hamilton, Paul Hamlin, Steven Horwitz, Erel Joffe, Anita Kumar, Matthew Matasar, Ariela Noy, Colette Owens, Alison Moskowitz, M. Lia Palomba, David Straus, Gottfried von Keudell, Ildefonso Rodriguez-Rivera, Lorenzo Falchi, Andrew Zelenetz, Joachim Yahalom, Anas Younes
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3382–3390.
https://doi.org/10.1182/bloodadvances.2020001551
Published: 2020
Includes: Supplemental data